Abstract: Provided is a method for reducing the amount of organic acids in a hydrocarbon oil fraction by hydrogenating the organic acids in the hydrocarbon oil fraction under mild conditions. Provided is a new method able to overcome the problem of organic-acid-induced corrosion during the process of distillation, by using hydrogen or a hydrogen-containing mixed gas and a hydrogenation catalyst to subject the organic acids in the hydrocarbon oil fraction to hydrogenation at an appropriate temperature and pressure, thereby converting the same to hydrocarbons and so reducing the amount of organic acids in the hydrocarbon oil fraction.

Abstract: Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Abstract: Disclosed herein are a method and apparatus for generating multiband Radio Frequency (RF) signals in maritime wireless communication. The apparatus includes a baseband conversion unit, a phase compensation unit, a Direct Current (DC) offset compensation unit, and an RF transmission unit. The baseband conversion unit converts RF signals corresponding to a baseband modulation signal having a negative frequency and a baseband modulation signal having a positive frequency into baseband signals, respectively. The phase compensation unit eliminates the images of multiband signals so as to correspond to the baseband signals. The DC offset compensation unit compensates the baseband modulation signals for DC offsets using the multiband signals from which the images have been eliminated. The RF transmission unit generates the RF signals using the signals which have been compensated for the DC offsets, and sends the RF signals via an antenna.

Abstract: Disclosed is a novel compound acting as a cannabinoid receptor 1 inhibitor, the compound being a pyrazolo[1,5-a]pyrimidine derivative, a prodrug thereof, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by the cannabinoid receptor-1.

Abstract: The present invention relates to a method and apparatus in which an Automatic Identification System (AIS) accesses a radio channel. The present invention includes selecting a slot on which a packet is to be transmitted on at least one radio channel, temporarily sending a first carrier, notifying other AISs that the selected slot has been selected by the AIS, on the selected slot in transmission mode, and after temporarily sending the first carrier, detecting a second carrier transmitted by another device on the selected slot in reception mode. In accordance with the present invention, the AIS temporarily sends a first carrier, notifying other AISs that a selected slot has been selected by the AIS, on the selected slot prior to the detection of a second carrier, and another AIS accessing the same slot detects the first carrier temporarily transmitted. Accordingly, a collision between channels can be avoided.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Abstract: The present invention relates to an apparatus and method of performing wireless communication using multiple directional antennas. The transportation means according to the present invention includes at least two communication devices, wherein one of the at least two communication devices, communication device A, includes a directional antenna group 1, and the other communication device, communication device B, includes a directional antenna group 2, and wherein the communication device A performs directional antenna selection control of the directional antenna group 1 included in the communication device A depending on whether the communication device B is connected with a network. According to the present invention, one of the communication devices gains access to a satellite station, a base station, or other ships, at least one antenna of another communication device may be used to relay wireless communication and may play a role as a base station or an AP.

Abstract: Disclosed herein are a maritime communication apparatus and method. The maritime communication apparatus includes a land-based network communication unit, a maritime network communication unit, and a communication control unit. The land-based network communication unit communicates with a land-based communication network. The maritime network communication unit communicates with a maritime communication network. The communication control unit links the communication of the land-based network communication unit with the communication of the maritime network communication unit in accordance with a destination address of data provided by any one of the land-based network communication unit and the maritime network communication unit.

Abstract: This present disclosure relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present disclosure provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Abstract: Provided is a method for reducing the amount of organic acids in a hydrocarbon oil fraction by hydrogenating the organic acids in the hydrocarbon oil fraction under mild conditions. Provided is a new method able to overcome the problem of organic-acid-induced corrosion during the process of distillation, by using hydrogen or a hydrogen-containing mixed gas and a hydrogenation catalyst to subject the organic acids in the hydrocarbon oil fraction to hydrogenation at an appropriate temperature and pressure, thereby converting the same to hydrocarbons and so reducing the amount of organic acids in the hydrocarbon oil fraction.

Abstract: This present disclosure relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present disclosure provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Abstract: Disclosed is a novel compound acting as a cannabinoid receptor 1 inhibitor, a prodrug thereof, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by the cannabinoid receptor-1.

Abstract: Provided is poly(tetraphenyl)silole siloxane having quantum well structures, and thus, organic-inorganic hybrid polymers having these quantum well structures are applied to electronic devices, which allows flexible non-volatile TFT memory devices to be realized.

Abstract: A semiconductor test system includes a user device configured to operate a reference device in accordance with an interface signal based on a timing signal having a variable operating frequency, a pattern synthesis apparatus configured to measure an interval between adjacent edges of the timing signal transmitted from the user device, and extract a logic value of the interface signal in accordance with the timing signal so as to generate test pattern data, and a test device configured to receive the test pattern data, reconstruct the timing signal based on the measured interval, generate a test driving signal such that the logic value is extracted from a device under test (DUT) based on the reconstructed timing signal, and apply the test driving signal to the DUT so as to determine an operating state of the DUT.

Abstract: The present invention relates to novel thiourea derivatives as a modulator for vanilloid receptor (VR) and the pharmaceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflammatory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.

Abstract: 2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-? or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-? or PDE4.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.

Abstract: A composition for preventing and/or treating brain tumor, containing caffeine and/or its analog, and/or their pharmaceutically acceptable salt, as an active ingredient, is provided. The composition for preventing or treating brain tumor has an activity to inhibit invasion, migration, and proliferation of brain tumor cells, and thereby very effective for the prevention and treatment of brain tumor.

Abstract: This present disclosure relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present disclosure provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.